Pharmaceutical Technology

JULY 10, 2025

How will RFK Jr’s American dream for vaccines play out? Zentiva Group has entered into a licence and supply agreement with pharmaceutical company Lupin for the commercialisation of the latter’s biosimilar Certolizumab Pegol, a tumour necrosis factor alpha (TNFα) inhibitor medicine, across several markets.

Biosimilars

pharmaphorum

JULY 1, 2025

The Vaccination in the UK: Access, uptake and equity (PDF) report notes that, over the last decade, the uptake of vaccines in the UK has stalled and is in many cases falling, leading to outbreaks of preventable diseases such as measles and whooping cough.

Vaccines

Pharmaceutical Technology

JULY 4, 2025

How will RFK Jr’s American dream for vaccines play out? Biocon Biologics’ Denosumab biosimilars, Vevzuo and Evfraxy, have received marketing authorisation in the European Union (EU). Clinical trials have demonstrated that both biosimilars match the reference product’s safety, quality and efficacy standards.

Biosimilars

Pharmaceutical Technology

JULY 7, 2025

How will RFK Jr’s American dream for vaccines play out?

Packaging

Pharmaceutical Technology

JULY 11, 2025

How will RFK Jr’s American dream for vaccines play out? Go deeper with GlobalData Reports LOA and PTSR Model - Bevacizumab Biosimilar in Endometrial Cancer Reports LOA and PTSR Model - Iparomlimab + Tuvonralimab in Nasopharyngeal C. Data Insights The gold standard of business intelligence.

Packaging

pharmaphorum

JUNE 30, 2025

Nicole Raleigh 30 June, 2025 Rare diseases Bookmark this News Moderna shines spotlight on new flu vaccine data Moderna may be facing regulatory uncertainty in the US for its vaccine pipeline, but at least its clinical data is hitting the right notes. Oncology The Leukemia & Lymphoma Society at ASCO 2025: Blood cancers.

Diabetes

Pharmaceutical Technology

JULY 7, 2025

How will RFK Jr’s American dream for vaccines play out?

Labelling

Pharmaceutical Technology

JUNE 27, 2025

Trump’s ‘most favoured nation’ model comes at a time when the administration has been vocal on its support for generics and biosimilars – copycat drugs that offer patients a cheaper entry point to treatment. It also goes some way to explaining the sheer volume of patients turning to compounded GLP-1RAs for weight loss.

Drug Pricing

Pharmaceutical Technology

JUNE 13, 2025

While the overall MG market is expected to experience growth until 2034, continued generic erosion and the entry of biosimilars will be important barriers to growth. Generic erosion and the entry of biosimilars are expected to be particularly significant in the US MG market. Can pharma tariffs “Make America Manufacture Again”?

Biosimilars

pharmaphorum

JUNE 19, 2025

BIO 2025 this year came at a uniquely fraught moment for vaccination in the United States just days after HHS Secretary Robert F Kennedy Jr. BIO 2025 this year came at a uniquely fraught moment for vaccination in the United States just days after HHS Secretary Robert F Kennedy Jr. The economics are there.

Vaccines

pharmaphorum

JUNE 30, 2025

Today, the company revealed that its mRNA-based investigational seasonal influenza vaccine, mRNA-1010 , showed greater protective efficacy than a licensed flu jab in the phase 3 P304 trial involving adults aged 50 and over. Moderna said that the result – which showed its shot was around 26.6%

Vaccines

pharmaphorum

JULY 18, 2025

The plan is to bring the UK Health Security Agency s existing centres in Colindale, London, and Porton Down near Salisbury in Wiltshire, under one roof, consolidating national expertise in research into emerging pathogens and the production of vaccines. Market Access Sponsored Bridging research and clinical guidelines – interactive stra.

Diabetes

pharmaphorum

JUNE 6, 2025

R&D Life Sciences Industry Report - Biologics and Generics The importance of biosimilars only continues to grow, driven by the potential savings they are able to deliver to healthcare systems. R&D Deep Dive: Research and Development 2025 Every breakthrough in medicine, every new treatment that changes lives, starts with research.

Diabetes

pharmaphorum

JUNE 26, 2025

The CDCs newly constituted Advisory Committee on Immunization Practices (ACIP) has voted to recommend the removal of vaccine preservative, thimerosal, that has become a focal point for activists trying to link vaccines to autism. Of all the issues the ACIP needs to focus on, this is not a big issue. The American people deserve no less."

Vaccines

pharmaphorum

JUNE 11, 2025

It has already been speculated that AstraZenecas termination of a plan to invest £450 million in a new vaccine manufacturing plant in the UK came about in part because of the big increase in the VPAG rate for newer medicines from around 15% in 2024 and mid-single digits in the pre-pandemic era.

Diabetes

pharmaphorum

JULY 22, 2025

Image Phil Taylor 22 July, 2025 cancer vaccines Bookmark this News AstraZeneca reveals $50bn investment in US facilities Trumps pharma tariffs havent appeared yet, but AstraZeneca has joined several of its peers with big investments in US manufacturing and R&D. Medical affairs is evolving.

Vaccines

pharmaphorum

JULY 10, 2025

The motion took her to task for refusing to disclose messages exchanged with Pfizers Albert Bourla, at the height of the pandemic, concerning vaccine procurement contracts worth billions of euros. billion doses of Pfizer and BioNTechs Comirnaty COVID-19 vaccine.

Diabetes

pharmaphorum

JULY 10, 2025

The new data from the US Measles Tracker , hosted by the International Vaccine Access Center (IVAC) at the Johns Hopkins Bloomberg School of Public Health, suggests that the US is at risk of losing its measles elimination status, according to IVAC executive director William Moss, who co-leads the tracking project.

Vaccines